India indigenously develops new antibiotic for drug-resistant pneumonia Sub : Sci Sec: Health A new antibiotic for drug-resistant pneumonia: Company: Wockhardt Ltd, a Maharashtra-based pharmaceutical firm. Drug Name: Nafithromycin (Trade Name: Miqnaf). Purpose: First indigenously developed antibiotic for treating Community-Acquired Bacterial Pneumonia (CABP) in adults, particularly drug-resistant cases. Development Journey: 14 years of […]